The World Trade Organization announced on Friday that nineteen developing-country
officials had participated in the 3rd workshop designed to help their countries
make use of the pharmaceutical patents flexibilities in the WTO intellectual
property agreement, which took place between 3 and 5 December, 2007.
Held in Geneva, this three-day WTO Workshop on the TRIPS Agreement and Public
Health was part of the WTO technical cooperation and capacity-building activities
- TRIPS is “trade-related intellectual property rights”, the name
used for the WTO’s intellectual property agreement.
Like the first and second workshops in September 2005 and November 2006, this
gathering aimed to ensure that the participants have the information necessary
so that their countries can make use of the TRIPS Agreement’s flexibilities
for public health purposes.
Among other subjects, the workshop looked at the additional flexibility agreed
by members in August 2003 and December 2005 to allow generic versions of patented
medicines to be made under compulsory licence for export to countries that cannot
manufacture the medicines themselves, sometimes called the “paragraph
6 system”.
The workshop featured presentations by WTO officials, representatives of other
intergovernmental organizations such as the World Intellectual Property Organization
(WIPO), World Health Organization (WHO), Global Fund, and UN Development Program
(UNDP), representatives of non-governmental organizations such as the International
Federation of Pharmaceutical Manufacturers (IFPMA), Médecins Sans Frontières
(MSF) and representatives of some WTO member governments.
The participants came from: Argentina, Brazil, Cuba, the Gambia, Hong Kong
China, India, Indonesia, Iran, Jamaica, Malaysia, Mali, Namibia, Peru, Philippines,
Saudi Arabia, Singapore, Turkey, Vietnam and Zambia.